2018 annual financial data
Nektar Therapeutics 2018 Operating cash flow margin
Direct answer
Operating cash flow margin was 60.19%.
Operating income was 687,932,000 USD and net income was 681,313,000 USD.
Operating cash flow was 718,214,000 USD.
Get free Nektar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,193,323,000 USD
- Operating income
- 687,932,000 USD
- Net income
- 681,313,000 USD
- Operating cash flow
- 718,214,000 USD